dbPTM

SF3B2_HUMAN - PTM Information in dbPTM

Basic Information of Protein

Overview of Protein Modification Sites with Functional and Structural Information
UniProt ID	SF3B2_HUMAN
UniProt AC	Q13435
Protein Name	Splicing factor 3B subunit 2
Gene Name	SF3B2
Organism	Homo sapiens (Human).
Sequence Length	895
Subcellular Localization	Nucleus . Nucleus speckle .
Protein Description	Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex. [PubMed: 27720643 SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA]
Protein Sequence	MATEHPEPPKAELQLPPPPPPGHYGAWAAQELQAKLAEIGAPIQGNREELVERLQSYTRQTGIVLNRPVLRGEDGDKAAPPPMSAQLPGIPMPPPPLGLPPLQPPPPPPPPPPGLGLGFPMAHPPNLGPPPPLRVGEPVALSEEERLKLAQQQAALLMQQEERAKQQGDHSLKEHELLEQQKRAAVLLEQERQQEIAKMGTPVPRPPQDMGQIGVRTPLGPRVAAPVGPVGPTPTVLPMGAPVPRPRGPPPPPGDENREMDDPSVGPKIPQALEKILQLKESRQEEMNSQQEEEEMETDARSSLGQSASETEEDTVSVSKKEKNRKRRNRKKKKKPQRVRGVSSESSGDREKDSTRSRGSDSPAADVEIEYVTEEPEIYEPNFIFFKRIFEAFKLTDDVKKEKEKEPEKLDKLENSAAPKKKGFEEEHKDSDDDSSDDEQEKKPEAPKLSKKKLRRMNRFTVAELKQLVARPDVVEMHDVTAQDPKLLVHLKATRNSVPVPRHWCFKRKYLQGKRGIEKPPFELPDFIKRTGIQEMREALQEKEEQKTMKSKMREKVRPKMGKIDIDYQKLHDAFFKWQTKPKLTIHGDLYYEGKEFETRLKEKKPGDLSDELRISLGMPVGPNAHKVPPPWLIAMQRYGPPPSYPNLKIPGLNSPIPESCSFGYHAGGWGKPPVDETGKPLYGDVFGTNAAEFQTKTEEEEIDRTPWGELEPSDEESSEEEEEEESDEDKPDETGFITPADSGLITPGGFSSVPAGMETPELIELRKKKIEEAMDGSETPQLFTVLPEKRTATVGGAMMGSTHIYDMSTVMSRKGPAPELQGVEVALAPEELELDPMAMTQKYEEHVREQQAQVEKEDFSDMVAEHAAKQKQKKRKAQPQDSRGGSKKYKEFKF

Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations	Modification	Substrate Peptides & Secondary Structure	ASA (%)	Reference
10	Sumoylation	TEHPEPPKAELQLPP CCCCCCCCCCCCCCC	66.27	28112733
71	Methylation	VLNRPVLRGEDGDKA EECCCEECCCCCCCC	46.84	115916649
142	Phosphorylation	VGEPVALSEEERLKL CCCCCCCCHHHHHHH	32.97	21815630
148	Acetylation	LSEEERLKLAQQQAA CCHHHHHHHHHHHHH	48.26	25953088
148	Ubiquitination	LSEEERLKLAQQQAA CCHHHHHHHHHHHHH	48.26	32015554
158	Sulfoxidation	QQQAALLMQQEERAK HHHHHHHHHHHHHHH	3.93	21406390
171	Phosphorylation	AKQQGDHSLKEHELL HHHHCCCCHHHHHHH	45.97	28555341
173	Ubiquitination	QQGDHSLKEHELLEQ HHCCCCHHHHHHHHH	61.10	32015554
178	Phosphorylation	SLKEHELLEQQKRAA CHHHHHHHHHHHHHH	5.20	18669648
182	Ubiquitination	HELLEQQKRAAVLLE HHHHHHHHHHHHHHH	43.64	32015554
192	Methylation	AVLLEQERQQEIAKM HHHHHHHHHHHHHHC	43.08	115916629
194	Phosphorylation	LLEQERQQEIAKMGT HHHHHHHHHHHHCCC	50.73	18669648
197	Ubiquitination	QERQQEIAKMGTPVP HHHHHHHHHCCCCCC	8.60	24816145
198	Ubiquitination	ERQQEIAKMGTPVPR HHHHHHHHCCCCCCC	43.45	24816145
201	Phosphorylation	QEIAKMGTPVPRPPQ HHHHHCCCCCCCCCC	20.02	21712546
205	Dimethylation	KMGTPVPRPPQDMGQ HCCCCCCCCCCCCCC	56.62	-
205	Methylation	KMGTPVPRPPQDMGQ HCCCCCCCCCCCCCC	56.62	54559177
216	Dimethylation	DMGQIGVRTPLGPRV CCCCCCCCCCCCCCC	25.97	-
216	Methylation	DMGQIGVRTPLGPRV CCCCCCCCCCCCCCC	25.97	30761005
217	Phosphorylation	MGQIGVRTPLGPRVA CCCCCCCCCCCCCCC	22.06	25159151
222	Dimethylation	VRTPLGPRVAAPVGP CCCCCCCCCCCCCCC	28.98	-
222	Methylation	VRTPLGPRVAAPVGP CCCCCCCCCCCCCCC	28.98	24129315
233	Phosphorylation	PVGPVGPTPTVLPMG CCCCCCCCCCEECCC	26.18	28555341
239	Sulfoxidation	PTPTVLPMGAPVPRP CCCCEECCCCCCCCC	6.64	21406390
245	Dimethylation	PMGAPVPRPRGPPPP CCCCCCCCCCCCCCC	33.51	-
245	Methylation	PMGAPVPRPRGPPPP CCCCCCCCCCCCCCC	33.51	24129315
247	Dimethylation	GAPVPRPRGPPPPPG CCCCCCCCCCCCCCC	72.09	-
247	Methylation	GAPVPRPRGPPPPPG CCCCCCCCCCCCCCC	72.09	24129315
258	Methylation	PPPGDENREMDDPSV CCCCCCCCCCCCCCC	38.27	115916633
260	Sulfoxidation	PGDENREMDDPSVGP CCCCCCCCCCCCCCC	6.81	21406390
264	Phosphorylation	NREMDDPSVGPKIPQ CCCCCCCCCCCCHHH	46.85	28555341
266	Phosphorylation	EMDDPSVGPKIPQAL CCCCCCCCCCHHHHH	23.32	18669648
266	Ubiquitination	EMDDPSVGPKIPQAL CCCCCCCCCCHHHHH	23.32	24816145
267	Ubiquitination	MDDPSVGPKIPQALE CCCCCCCCCHHHHHH	29.28	24816145
268	Acetylation	DDPSVGPKIPQALEK CCCCCCCCHHHHHHH	62.18	26051181
268	Methylation	DDPSVGPKIPQALEK CCCCCCCCHHHHHHH	62.18	115916621
268	Ubiquitination	DDPSVGPKIPQALEK CCCCCCCCHHHHHHH	62.18	24816145
273	Ubiquitination	GPKIPQALEKILQLK CCCHHHHHHHHHHHH	6.08	21890473
274	Ubiquitination	PKIPQALEKILQLKE CCHHHHHHHHHHHHH	40.86	21890473
275	Ubiquitination	KIPQALEKILQLKES CHHHHHHHHHHHHHH	49.95	21890473
275	Ubiquitination	KIPQALEKILQLKES CHHHHHHHHHHHHHH	49.95	21890473
275	Acetylation	KIPQALEKILQLKES CHHHHHHHHHHHHHH	49.95	19608861
275	Ubiquitination	KIPQALEKILQLKES CHHHHHHHHHHHHHH	49.95	23000965
275	Ubiquitination	KIPQALEKILQLKES CHHHHHHHHHHHHHH	49.95	21890473
275	Ubiquitination	KIPQALEKILQLKES CHHHHHHHHHHHHHH	49.95	21890473
275	Ubiquitination	KIPQALEKILQLKES CHHHHHHHHHHHHHH	49.95	21890473
278	Ubiquitination	QALEKILQLKESRQE HHHHHHHHHHHHHHH	54.70	23000965
279	Phosphorylation	ALEKILQLKESRQEE HHHHHHHHHHHHHHH	6.27	18669648
279	Ubiquitination	ALEKILQLKESRQEE HHHHHHHHHHHHHHH	6.27	23000965
280	Ubiquitination	LEKILQLKESRQEEM HHHHHHHHHHHHHHH	40.46	21890473
280	Ubiquitination	LEKILQLKESRQEEM HHHHHHHHHHHHHHH	40.46	21890473
280	Acetylation	LEKILQLKESRQEEM HHHHHHHHHHHHHHH	40.46	25953088
280	Phosphorylation	LEKILQLKESRQEEM HHHHHHHHHHHHHHH	40.46	18669648
280	Sumoylation	LEKILQLKESRQEEM HHHHHHHHHHHHHHH	40.46	28112733
280	Ubiquitination	LEKILQLKESRQEEM HHHHHHHHHHHHHHH	40.46	23000965
280	Ubiquitination	LEKILQLKESRQEEM HHHHHHHHHHHHHHH	40.46	21890473
280	Ubiquitination	LEKILQLKESRQEEM HHHHHHHHHHHHHHH	40.46	21890473
280	Ubiquitination	LEKILQLKESRQEEM HHHHHHHHHHHHHHH	40.46	21890473
282	Phosphorylation	KILQLKESRQEEMNS HHHHHHHHHHHHHHH	37.36	22199227
284	Phosphorylation	LQLKESRQEEMNSQQ HHHHHHHHHHHHHHH	61.35	18669648
286	Phosphorylation	LKESRQEEMNSQQEE HHHHHHHHHHHHHHH	35.01	18669648
287	Sulfoxidation	KESRQEEMNSQQEEE HHHHHHHHHHHHHHH	6.02	28465586
288	Phosphorylation	ESRQEEMNSQQEEEE HHHHHHHHHHHHHHH	39.69	18669648
289	Phosphorylation	SRQEEMNSQQEEEEM HHHHHHHHHHHHHHH	31.75	17525332
296	Sulfoxidation	SQQEEEEMETDARSS HHHHHHHHHHHHHHH	8.32	28465586
298	Phosphorylation	QEEEEMETDARSSLG HHHHHHHHHHHHHHC	33.38	21815630
302	Phosphorylation	EMETDARSSLGQSAS HHHHHHHHHHCCCCC	31.47	25159151
303	Phosphorylation	METDARSSLGQSASE HHHHHHHHHCCCCCC	30.85	23927012
307	Phosphorylation	ARSSLGQSASETEED HHHHHCCCCCCCCCC	31.78	19664994
309	Phosphorylation	SSLGQSASETEEDTV HHHCCCCCCCCCCCC	50.74	19664994
311	Phosphorylation	LGQSASETEEDTVSV HCCCCCCCCCCCCCC	42.03	29255136
315	Phosphorylation	ASETEEDTVSVSKKE CCCCCCCCCCCCHHH	20.26	25463755
317	Phosphorylation	ETEEDTVSVSKKEKN CCCCCCCCCCHHHHH	23.83	25159151
319	Phosphorylation	EEDTVSVSKKEKNRK CCCCCCCCHHHHHHH	30.42	23927012
319	Ubiquitination	EEDTVSVSKKEKNRK CCCCCCCCHHHHHHH	30.42	24816145
320	Phosphorylation	EDTVSVSKKEKNRKR CCCCCCCHHHHHHHH	63.90	17287340
320	Ubiquitination	EDTVSVSKKEKNRKR CCCCCCCHHHHHHHH	63.90	24816145
321	Ubiquitination	DTVSVSKKEKNRKRR CCCCCCHHHHHHHHH	67.43	24816145
332	Ubiquitination	RKRRNRKKKKKPQRV HHHHHHHHCCCCHHH	67.59	24816145
333	Ubiquitination	KRRNRKKKKKPQRVR HHHHHHHCCCCHHHC	69.89	24816145
334	Ubiquitination	RRNRKKKKKPQRVRG HHHHHHCCCCHHHCC	77.79	24816145
337	Phosphorylation	RKKKKKPQRVRGVSS HHHCCCCHHHCCCCC	66.44	17287340
340	Methylation	KKKPQRVRGVSSESS CCCCHHHCCCCCCCC	41.82	115916637
343	Phosphorylation	PQRVRGVSSESSGDR CHHHCCCCCCCCCCC	31.08	23401153
344	Phosphorylation	QRVRGVSSESSGDRE HHHCCCCCCCCCCCC	38.81	27273156
346	Phosphorylation	VRGVSSESSGDREKD HCCCCCCCCCCCCCC	41.38	23401153
347	Phosphorylation	RGVSSESSGDREKDS CCCCCCCCCCCCCCC	40.43	26055452
350	Ubiquitination	SSESSGDREKDSTRS CCCCCCCCCCCCCCC	57.29	22817900
351	Ubiquitination	SESSGDREKDSTRSR CCCCCCCCCCCCCCC	66.99	22817900
352	Acetylation	ESSGDREKDSTRSRG CCCCCCCCCCCCCCC	58.85	25953088
352	Ubiquitination	ESSGDREKDSTRSRG CCCCCCCCCCCCCCC	58.85	22817900
357	Phosphorylation	REKDSTRSRGSDSPA CCCCCCCCCCCCCCC	40.87	25159151
360	Phosphorylation	DSTRSRGSDSPAADV CCCCCCCCCCCCCCE	33.53	25159151
362	Phosphorylation	TRSRGSDSPAADVEI CCCCCCCCCCCCEEE	20.38	25159151
370	Ubiquitination	PAADVEIEYVTEEPE CCCCEEEEEECCCCC	22.05	21890473
371	Phosphorylation	AADVEIEYVTEEPEI CCCEEEEEECCCCCC	20.52	24043423
373	Phosphorylation	DVEIEYVTEEPEIYE CEEEEEECCCCCCCC	33.46	24043423
379	Phosphorylation	VTEEPEIYEPNFIFF ECCCCCCCCCCCCHH	24.54	20873877
385	Ubiquitination	IYEPNFIFFKRIFEA CCCCCCCHHHHHHHH	5.30	21963094
386	Ubiquitination	YEPNFIFFKRIFEAF CCCCCCHHHHHHHHH	4.43	21963094
387	Ubiquitination	EPNFIFFKRIFEAFK CCCCCHHHHHHHHHH	33.56	21963094
390	Ubiquitination	FIFFKRIFEAFKLTD CCHHHHHHHHHHCCH	6.86	21890473
392	Ubiquitination	FFKRIFEAFKLTDDV HHHHHHHHHHCCHHH	8.98	23000965
393	Ubiquitination	FKRIFEAFKLTDDVK HHHHHHHHHCCHHHH	5.40	23000965
394	Acetylation	KRIFEAFKLTDDVKK HHHHHHHHCCHHHHH	58.48	25953088
394	Ubiquitination	KRIFEAFKLTDDVKK HHHHHHHHCCHHHHH	58.48	23000965
396	Phosphorylation	IFEAFKLTDDVKKEK HHHHHHCCHHHHHHH	30.64	28555341
396	Ubiquitination	IFEAFKLTDDVKKEK HHHHHHCCHHHHHHH	30.64	21890473
398	Ubiquitination	EAFKLTDDVKKEKEK HHHHCCHHHHHHHHH	49.23	23000965
399	Ubiquitination	AFKLTDDVKKEKEKE HHHCCHHHHHHHHHC	12.12	23000965
400	Sumoylation	FKLTDDVKKEKEKEP HHCCHHHHHHHHHCH	63.31	-
400	2-Hydroxyisobutyrylation	FKLTDDVKKEKEKEP HHCCHHHHHHHHHCH	63.31	-
400	Acetylation	FKLTDDVKKEKEKEP HHCCHHHHHHHHHCH	63.31	25953088
400	Sumoylation	FKLTDDVKKEKEKEP HHCCHHHHHHHHHCH	63.31	28112733
400	Ubiquitination	FKLTDDVKKEKEKEP HHCCHHHHHHHHHCH	63.31	23000965
401	Ubiquitination	KLTDDVKKEKEKEPE HCCHHHHHHHHHCHH	74.08	22817900
402	Ubiquitination	LTDDVKKEKEKEPEK CCHHHHHHHHHCHHH	61.81	22817900
403	Ubiquitination	TDDVKKEKEKEPEKL CHHHHHHHHHCHHHH	80.91	22817900
404	Ubiquitination	DDVKKEKEKEPEKLD HHHHHHHHHCHHHHH	64.84	22817900
405	Ubiquitination	DVKKEKEKEPEKLDK HHHHHHHHCHHHHHH	84.98	22817900
407	Ubiquitination	KKEKEKEPEKLDKLE HHHHHHCHHHHHHHC	55.90	23000965
408	Phosphorylation	KEKEKEPEKLDKLEN HHHHHCHHHHHHHCC	68.30	18669648
408	Ubiquitination	KEKEKEPEKLDKLEN HHHHHCHHHHHHHCC	68.30	23000965
409	Ubiquitination	EKEKEPEKLDKLENS HHHHCHHHHHHHCCC	73.10	23000965
410	Ubiquitination	KEKEPEKLDKLENSA HHHCHHHHHHHCCCC	7.19	23000965
411	Ubiquitination	EKEPEKLDKLENSAA HHCHHHHHHHCCCCC	65.64	23000965
412	Sumoylation	KEPEKLDKLENSAAP HCHHHHHHHCCCCCC	69.04	-
412	Acetylation	KEPEKLDKLENSAAP HCHHHHHHHCCCCCC	69.04	23236377
412	Phosphorylation	KEPEKLDKLENSAAP HCHHHHHHHCCCCCC	69.04	18669648
412	Sumoylation	KEPEKLDKLENSAAP HCHHHHHHHCCCCCC	69.04	28112733
412	Ubiquitination	KEPEKLDKLENSAAP HCHHHHHHHCCCCCC	69.04	23000965
413	Phosphorylation	EPEKLDKLENSAAPK CHHHHHHHCCCCCCC	8.22	18669648
416	Phosphorylation	KLDKLENSAAPKKKG HHHHHCCCCCCCCCC	19.21	29255136
420	2-Hydroxyisobutyrylation	LENSAAPKKKGFEEE HCCCCCCCCCCCHHH	63.49	-
420	Ubiquitination	LENSAAPKKKGFEEE HCCCCCCCCCCCHHH	63.49	33845483
431	Phosphorylation	FEEEHKDSDDDSSDD CHHHCCCCCCCCCHH	47.98	26846344
433	Ubiquitination	EEHKDSDDDSSDDEQ HHCCCCCCCCCHHHH	62.74	21890473
435	Phosphorylation	HKDSDDDSSDDEQEK CCCCCCCCCHHHHHH	42.53	26846344
436	Phosphorylation	KDSDDDSSDDEQEKK CCCCCCCCHHHHHHC	56.95	26846344
441	Ubiquitination	DSSDDEQEKKPEAPK CCCHHHHHHCCCCCC	62.08	27667366
442	Ubiquitination	SSDDEQEKKPEAPKL CCHHHHHHCCCCCCC	73.63	27667366
443	Ubiquitination	SDDEQEKKPEAPKLS CHHHHHHCCCCCCCC	47.54	27667366
450	Phosphorylation	KPEAPKLSKKKLRRM CCCCCCCCHHHHHHC	48.86	25159151
461	Phosphorylation	LRRMNRFTVAELKQL HHHCCCCCHHHHHHH	18.64	28555341
464	Ubiquitination	MNRFTVAELKQLVAR CCCCCHHHHHHHHHC	52.76	21890473
465	Ubiquitination	NRFTVAELKQLVARP CCCCHHHHHHHHHCC	2.86	21890473
466	Ubiquitination	RFTVAELKQLVARPD CCCHHHHHHHHHCCC	32.84	21890473
466	Ubiquitination	RFTVAELKQLVARPD CCCHHHHHHHHHCCC	32.84	21890473
466	Ubiquitination	RFTVAELKQLVARPD CCCHHHHHHHHHCCC	32.84	22817900
466	Ubiquitination	RFTVAELKQLVARPD CCCHHHHHHHHHCCC	32.84	21890473
466	Ubiquitination	RFTVAELKQLVARPD CCCHHHHHHHHHCCC	32.84	21890473
466	Ubiquitination	RFTVAELKQLVARPD CCCHHHHHHHHHCCC	32.84	21890473
474	Ubiquitination	QLVARPDVVEMHDVT HHHHCCCEEEEECCC	4.32	21890473
481	Ubiquitination	VVEMHDVTAQDPKLL EEEEECCCCCCCCEE	25.34	21890473
484	Ubiquitination	MHDVTAQDPKLLVHL EECCCCCCCCEEEEE	39.58	21890473
485	Ubiquitination	HDVTAQDPKLLVHLK ECCCCCCCCEEEEEE	19.67	21890473
486	Ubiquitination	DVTAQDPKLLVHLKA CCCCCCCCEEEEEEE	63.84	21890473
486	Ubiquitination	DVTAQDPKLLVHLKA CCCCCCCCEEEEEEE	63.84	21890473
486	2-Hydroxyisobutyrylation	DVTAQDPKLLVHLKA CCCCCCCCEEEEEEE	63.84	-
486	Acetylation	DVTAQDPKLLVHLKA CCCCCCCCEEEEEEE	63.84	26051181
486	Ubiquitination	DVTAQDPKLLVHLKA CCCCCCCCEEEEEEE	63.84	23000965
486	Ubiquitination	DVTAQDPKLLVHLKA CCCCCCCCEEEEEEE	63.84	21890473
486	Ubiquitination	DVTAQDPKLLVHLKA CCCCCCCCEEEEEEE	63.84	21890473
486	Ubiquitination	DVTAQDPKLLVHLKA CCCCCCCCEEEEEEE	63.84	21890473
490	Ubiquitination	QDPKLLVHLKATRNS CCCCEEEEEEECCCC	22.91	21890473
491	Ubiquitination	DPKLLVHLKATRNSV CCCEEEEEEECCCCC	2.92	21890473
492	Ubiquitination	PKLLVHLKATRNSVP CCEEEEEEECCCCCC	32.60	21890473
492	Ubiquitination	PKLLVHLKATRNSVP CCEEEEEEECCCCCC	32.60	21890473
492	Methylation	PKLLVHLKATRNSVP CCEEEEEEECCCCCC	32.60	21685013
492	Sumoylation	PKLLVHLKATRNSVP CCEEEEEEECCCCCC	32.60	28112733
492	Ubiquitination	PKLLVHLKATRNSVP CCEEEEEEECCCCCC	32.60	23000965
492	Ubiquitination	PKLLVHLKATRNSVP CCEEEEEEECCCCCC	32.60	21890473
492	Ubiquitination	PKLLVHLKATRNSVP CCEEEEEEECCCCCC	32.60	21890473
492	Ubiquitination	PKLLVHLKATRNSVP CCEEEEEEECCCCCC	32.60	21890473
502	Dimethylation	RNSVPVPRHWCFKRK CCCCCCCCHHHHHHH	35.85	-
502	Methylation	RNSVPVPRHWCFKRK CCCCCCCCHHHHHHH	35.85	24383531
507	Methylation	VPRHWCFKRKYLQGK CCCHHHHHHHHHCCC	44.86	23748837
508	Dimethylation	PRHWCFKRKYLQGKR CCHHHHHHHHHCCCC	16.76	-
508	Methylation	PRHWCFKRKYLQGKR CCHHHHHHHHHCCCC	16.76	25737013
512	Ubiquitination	CFKRKYLQGKRGIEK HHHHHHHCCCCCCCC	52.88	22817900
513	Ubiquitination	FKRKYLQGKRGIEKP HHHHHHCCCCCCCCC	21.02	22817900
514	Ubiquitination	KRKYLQGKRGIEKPP HHHHHCCCCCCCCCC	34.19	22817900
515	Methylation	RKYLQGKRGIEKPPF HHHHCCCCCCCCCCC	59.14	24129315
517	Ubiquitination	YLQGKRGIEKPPFEL HHCCCCCCCCCCCCC	7.75	22817900
518	Ubiquitination	LQGKRGIEKPPFELP HCCCCCCCCCCCCCC	63.43	22817900
519	Acetylation	QGKRGIEKPPFELPD CCCCCCCCCCCCCCH	56.95	26051181
519	Ubiquitination	QGKRGIEKPPFELPD CCCCCCCCCCCCCCH	56.95	21906983
527	Ubiquitination	PPFELPDFIKRTGIQ CCCCCCHHHHHHCHH	7.19	23000965
528	Ubiquitination	PFELPDFIKRTGIQE CCCCCHHHHHHCHHH	3.73	23000965
529	Ubiquitination	FELPDFIKRTGIQEM CCCCHHHHHHCHHHH	43.85	21890473
529	Ubiquitination	FELPDFIKRTGIQEM CCCCHHHHHHCHHHH	43.85	21890473
529	2-Hydroxyisobutyrylation	FELPDFIKRTGIQEM CCCCHHHHHHCHHHH	43.85	-
529	Acetylation	FELPDFIKRTGIQEM CCCCHHHHHHCHHHH	43.85	26051181
529	Ubiquitination	FELPDFIKRTGIQEM CCCCHHHHHHCHHHH	43.85	23000965
529	Ubiquitination	FELPDFIKRTGIQEM CCCCHHHHHHCHHHH	43.85	21890473
529	Ubiquitination	FELPDFIKRTGIQEM CCCCHHHHHHCHHHH	43.85	21890473
529	Ubiquitination	FELPDFIKRTGIQEM CCCCHHHHHHCHHHH	43.85	21890473
531	Phosphorylation	LPDFIKRTGIQEMRE CCHHHHHHCHHHHHH	33.37	26074081
537	Methylation	RTGIQEMREALQEKE HHCHHHHHHHHHHHH	25.86	115916641
541	Ubiquitination	QEMREALQEKEEQKT HHHHHHHHHHHHHHH	67.76	22817900
542	Ubiquitination	EMREALQEKEEQKTM HHHHHHHHHHHHHHH	64.38	22817900
543	Acetylation	MREALQEKEEQKTMK HHHHHHHHHHHHHHH	54.30	23749302
543	Sumoylation	MREALQEKEEQKTMK HHHHHHHHHHHHHHH	54.30	28112733
543	Ubiquitination	MREALQEKEEQKTMK HHHHHHHHHHHHHHH	54.30	21906983
545	Ubiquitination	EALQEKEEQKTMKSK HHHHHHHHHHHHHHH	69.33	22817900
546	Ubiquitination	ALQEKEEQKTMKSKM HHHHHHHHHHHHHHH	47.84	22817900
547	Acetylation	LQEKEEQKTMKSKMR HHHHHHHHHHHHHHH	54.59	26051181
547	Ubiquitination	LQEKEEQKTMKSKMR HHHHHHHHHHHHHHH	54.59	22817900
548	Phosphorylation	QEKEEQKTMKSKMRE HHHHHHHHHHHHHHH	29.53	-
558	Ubiquitination	SKMREKVRPKMGKID HHHHHHHHHCCCCCC	35.87	22817900
559	Ubiquitination	KMREKVRPKMGKIDI HHHHHHHHCCCCCCC	33.69	22817900
560	Ubiquitination	MREKVRPKMGKIDID HHHHHHHCCCCCCCC	50.12	22817900
561	Ubiquitination	REKVRPKMGKIDIDY HHHHHHCCCCCCCCH	7.97	22817900
562	Ubiquitination	EKVRPKMGKIDIDYQ HHHHHCCCCCCCCHH	29.87	22817900
563	Acetylation	KVRPKMGKIDIDYQK HHHHCCCCCCCCHHH	33.44	25953088
563	Ubiquitination	KVRPKMGKIDIDYQK HHHHCCCCCCCCHHH	33.44	21906983
568	Phosphorylation	MGKIDIDYQKLHDAF CCCCCCCHHHHHHHH	14.10	-
568	Ubiquitination	MGKIDIDYQKLHDAF CCCCCCCHHHHHHHH	14.10	21890473
569	Ubiquitination	GKIDIDYQKLHDAFF CCCCCCHHHHHHHHH	37.78	21890473
570	Ubiquitination	KIDIDYQKLHDAFFK CCCCCHHHHHHHHHH	41.37	21890473
570	Ubiquitination	KIDIDYQKLHDAFFK CCCCCHHHHHHHHHH	41.37	21890473
570	2-Hydroxyisobutyrylation	KIDIDYQKLHDAFFK CCCCCHHHHHHHHHH	41.37	-
570	Acetylation	KIDIDYQKLHDAFFK CCCCCHHHHHHHHHH	41.37	26051181
570	Ubiquitination	KIDIDYQKLHDAFFK CCCCCHHHHHHHHHH	41.37	23000965
570	Ubiquitination	KIDIDYQKLHDAFFK CCCCCHHHHHHHHHH	41.37	21890473
570	Ubiquitination	KIDIDYQKLHDAFFK CCCCCHHHHHHHHHH	41.37	21890473
570	Ubiquitination	KIDIDYQKLHDAFFK CCCCCHHHHHHHHHH	41.37	21890473
575	Ubiquitination	YQKLHDAFFKWQTKP HHHHHHHHHHCCCCC	8.90	21890473
576	Ubiquitination	QKLHDAFFKWQTKPK HHHHHHHHHCCCCCC	9.36	21890473
577	Ubiquitination	KLHDAFFKWQTKPKL HHHHHHHHCCCCCCE	31.75	21890473
577	Ubiquitination	KLHDAFFKWQTKPKL HHHHHHHHCCCCCCE	31.75	21890473
577	Acetylation	KLHDAFFKWQTKPKL HHHHHHHHCCCCCCE	31.75	25825284
577	Ubiquitination	KLHDAFFKWQTKPKL HHHHHHHHCCCCCCE	31.75	23000965
577	Ubiquitination	KLHDAFFKWQTKPKL HHHHHHHHCCCCCCE	31.75	21890473
577	Ubiquitination	KLHDAFFKWQTKPKL HHHHHHHHCCCCCCE	31.75	21890473
577	Ubiquitination	KLHDAFFKWQTKPKL HHHHHHHHCCCCCCE	31.75	21890473
579	Ubiquitination	HDAFFKWQTKPKLTI HHHHHHCCCCCCEEE	39.99	23000965
580	Ubiquitination	DAFFKWQTKPKLTIH HHHHHCCCCCCEEEE	48.47	23000965
581	Ubiquitination	AFFKWQTKPKLTIHG HHHHCCCCCCEEEEE	25.67	23000965
582	Ubiquitination	FFKWQTKPKLTIHGD HHHCCCCCCEEEEEE	40.03	23000965
583	Ubiquitination	FKWQTKPKLTIHGDL HHCCCCCCEEEEEEE	60.87	23000965
591	Phosphorylation	LTIHGDLYYEGKEFE EEEEEEEEECCCHHH	12.29	25884760
592	Phosphorylation	TIHGDLYYEGKEFET EEEEEEEECCCHHHH	26.04	25159151
595	Acetylation	GDLYYEGKEFETRLK EEEEECCCHHHHHHC	47.49	26051181
595	Ubiquitination	GDLYYEGKEFETRLK EEEEECCCHHHHHHC	47.49	33845483
602	Ubiquitination	KEFETRLKEKKPGDL CHHHHHHCCCCCCCC	65.28	24816145
603	Ubiquitination	EFETRLKEKKPGDLS HHHHHHCCCCCCCCC	71.54	24816145
604	Ubiquitination	FETRLKEKKPGDLSD HHHHHCCCCCCCCCC	63.78	24816145
605	Sumoylation	ETRLKEKKPGDLSDE HHHHCCCCCCCCCCC	56.15	-
605	Sumoylation	ETRLKEKKPGDLSDE HHHHCCCCCCCCCCC	56.15	-
605	Ubiquitination	ETRLKEKKPGDLSDE HHHHCCCCCCCCCCC	56.15	33845483
610	Phosphorylation	EKKPGDLSDELRISL CCCCCCCCCCHHHHC	33.50	29507054
614	Methylation	GDLSDELRISLGMPV CCCCCCHHHHCCCCC	17.88	115916645
625	Ubiquitination	GMPVGPNAHKVPPPW CCCCCCCCCCCCCCC	13.65	23000965
626	Ubiquitination	MPVGPNAHKVPPPWL CCCCCCCCCCCCCCE	37.98	23000965
627	Ubiquitination	PVGPNAHKVPPPWLI CCCCCCCCCCCCCEE	54.77	23000965
639	Phosphorylation	WLIAMQRYGPPPSYP CEEEEHHHCCCCCCC	19.66	28152594
644	Phosphorylation	QRYGPPPSYPNLKIP HHHCCCCCCCCCCCC	60.02	28152594
645	Phosphorylation	RYGPPPSYPNLKIPG HHCCCCCCCCCCCCC	11.25	28152594
655	Phosphorylation	LKIPGLNSPIPESCS CCCCCCCCCCCCCCC	29.28	25159151
672	Acetylation	YHAGGWGKPPVDETG CCCCCCCCCCCCCCC	39.37	26051181
672	Ubiquitination	YHAGGWGKPPVDETG CCCCCCCCCCCCCCC	39.37	29967540
680	Acetylation	PPVDETGKPLYGDVF CCCCCCCCCCCCCHH	38.99	26051181
680	Sumoylation	PPVDETGKPLYGDVF CCCCCCCCCCCCCHH	38.99	-
680	Ubiquitination	PPVDETGKPLYGDVF CCCCCCCCCCCCCHH	38.99	29967540
697	Sumoylation	NAAEFQTKTEEEEID CHHHHCCCCCHHHCC	43.06	-
698	Phosphorylation	AAEFQTKTEEEEIDR HHHHCCCCCHHHCCC	52.60	21815630
706	Phosphorylation	EEEEIDRTPWGELEP CHHHCCCCCCCCCCC	21.46	21406692
714	Phosphorylation	PWGELEPSDEESSEE CCCCCCCCCCCCCHH	48.56	21406692
718	Phosphorylation	LEPSDEESSEEEEEE CCCCCCCCCHHHHHH	40.79	21406692
719	Phosphorylation	EPSDEESSEEEEEEE CCCCCCCCHHHHHHH	52.92	21406692
727	Phosphorylation	EEEEEEESDEDKPDE HHHHHHHCCCCCCCC	49.97	21406692
735	Phosphorylation	DEDKPDETGFITPAD CCCCCCCCCCCCCCC	44.78	21406692
739	Phosphorylation	PDETGFITPADSGLI CCCCCCCCCCCCCCC	15.34	20068231
743	Phosphorylation	GFITPADSGLITPGG CCCCCCCCCCCCCCC	37.29	21406692
747	Phosphorylation	PADSGLITPGGFSSV CCCCCCCCCCCCCCC	22.41	21406692
752	Phosphorylation	LITPGGFSSVPAGME CCCCCCCCCCCCCCC	33.43	21406692
753	Phosphorylation	ITPGGFSSVPAGMET CCCCCCCCCCCCCCC	29.83	21406692
755	Phosphorylation	PGGFSSVPAGMETPE CCCCCCCCCCCCCHH	25.66	18669648
757	Phosphorylation	GFSSVPAGMETPELI CCCCCCCCCCCHHHH	14.37	18669648
760	Phosphorylation	SVPAGMETPELIELR CCCCCCCCHHHHHHH	17.11	26657352
770	Sumoylation	LIELRKKKIEEAMDG HHHHHHHHHHHHHCC	59.39	-
770	Sumoylation	LIELRKKKIEEAMDG HHHHHHHHHHHHHCC	59.39	28112733
778	Phosphorylation	IEEAMDGSETPQLFT HHHHHCCCCCCCCEE	33.75	29255136
780	Phosphorylation	EAMDGSETPQLFTVL HHHCCCCCCCCEECC	20.31	29255136
783	Phosphorylation	DGSETPQLFTVLPEK CCCCCCCCEECCCCC	4.01	18669648
785	Phosphorylation	SETPQLFTVLPEKRT CCCCCCEECCCCCCC	29.71	27794612
786	Phosphorylation	ETPQLFTVLPEKRTA CCCCCEECCCCCCCC	7.04	18669648
787	Phosphorylation	TPQLFTVLPEKRTAT CCCCEECCCCCCCCE	4.05	18669648
788	Ubiquitination	PQLFTVLPEKRTATV CCCEECCCCCCCCEE	40.50	22817900
789	Ubiquitination	QLFTVLPEKRTATVG CCEECCCCCCCCEEC	51.51	22817900
790	Sumoylation	LFTVLPEKRTATVGG CEECCCCCCCCEECC	53.78	28112733
790	Ubiquitination	LFTVLPEKRTATVGG CEECCCCCCCCEECC	53.78	22817900
792	Phosphorylation	TVLPEKRTATVGGAM ECCCCCCCCEECCCC	37.43	30576142
794	Phosphorylation	LPEKRTATVGGAMMG CCCCCCCEECCCCCC	21.04	20068231
802	Phosphorylation	VGGAMMGSTHIYDMS ECCCCCCCEEEEEHH	10.02	20068231
803	Phosphorylation	GGAMMGSTHIYDMST CCCCCCCEEEEEHHH	13.43	20068231
806	Phosphorylation	MMGSTHIYDMSTVMS CCCCEEEEEHHHHHH	9.66	27259358
809	Phosphorylation	STHIYDMSTVMSRKG CEEEEEHHHHHHCCC	18.23	18669648
810	Phosphorylation	THIYDMSTVMSRKGP EEEEEHHHHHHCCCC	17.37	30576142
813	Phosphorylation	YDMSTVMSRKGPAPE EEHHHHHHCCCCCCC	26.89	20068231
815	Ubiquitination	MSTVMSRKGPAPELQ HHHHHHCCCCCCCCC	63.04	-
841	Phosphorylation	ELDPMAMTQKYEEHV CCCHHHHHHHHHHHH	16.63	30576142
841	Ubiquitination	ELDPMAMTQKYEEHV CCCHHHHHHHHHHHH	16.63	24816145
842	Ubiquitination	LDPMAMTQKYEEHVR CCHHHHHHHHHHHHH	33.00	24816145
843	Methylation	DPMAMTQKYEEHVRE CHHHHHHHHHHHHHH	45.52	116252643
843	Sumoylation	DPMAMTQKYEEHVRE CHHHHHHHHHHHHHH	45.52	28112733
843	Ubiquitination	DPMAMTQKYEEHVRE CHHHHHHHHHHHHHH	45.52	32015554
844	Phosphorylation	PMAMTQKYEEHVREQ HHHHHHHHHHHHHHH	19.41	27642862
855	Ubiquitination	VREQQAQVEKEDFSD HHHHHHHHHHHHHHH	14.74	24816145
856	Ubiquitination	REQQAQVEKEDFSDM HHHHHHHHHHHHHHH	38.35	24816145
857	2-Hydroxyisobutyrylation	EQQAQVEKEDFSDMV HHHHHHHHHHHHHHH	64.82	-
857	Acetylation	EQQAQVEKEDFSDMV HHHHHHHHHHHHHHH	64.82	26051181
857	Sumoylation	EQQAQVEKEDFSDMV HHHHHHHHHHHHHHH	64.82	28112733
857	Ubiquitination	EQQAQVEKEDFSDMV HHHHHHHHHHHHHHH	64.82	24816145
861	Phosphorylation	QVEKEDFSDMVAEHA HHHHHHHHHHHHHHH	36.80	29255136
863	Sulfoxidation	EKEDFSDMVAEHAAK HHHHHHHHHHHHHHH	2.74	21406390
870	Acetylation	MVAEHAAKQKQKKRK HHHHHHHHHHHHHHH	59.83	25953088
870	Ubiquitination	MVAEHAAKQKQKKRK HHHHHHHHHHHHHHH	59.83	32015554
883	Phosphorylation	RKAQPQDSRGGSKKY HHCCCCCCCCCCHHC	27.81	22496350
884	Methylation	KAQPQDSRGGSKKYK HCCCCCCCCCCHHCC	62.88	54559183
887	Phosphorylation	PQDSRGGSKKYKEFK CCCCCCCCHHCCCCC	28.88	26074081
890	Phosphorylation	SRGGSKKYKEFKF-- CCCCCHHCCCCCC--	21.34	26074081
891	Acetylation	RGGSKKYKEFKF--- CCCCHHCCCCCC---	66.60	7296823

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)

Modified Location	Modified Residue	Modification	Type of Upstream Proteins	Gene Name of Upstream Proteins	UniProt AC of Upstream Proteins	Sources
379	Y	Phosphorylation	Kinase	SRC	P12931	PSP
592	Y	Phosphorylation	Kinase	SRC	P12931	PSP

Functions of PTM Sites

Modified Location	Modified Residue	Modification	Function	Reference
508	R	Methylation		25737013
Methylation at Arg-508 by PRMT9 is required for the interaction with SMN1.

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location	Modification	Variant Position (Distance <= 10)	Residue Change	SAP	Related Disease	Reference
Oops, there are no SNP-PTM records of SF3B2_HUMAN !!

Protein-Protein Interaction

Interacting Protein	Gene Name	Interaction Type	PPI Reference
SF3B1_HUMAN	SF3B1	physical	10490618
SF3B3_HUMAN	SF3B3	physical	10490618
ECM29_HUMAN	KIAA0368	physical	20682791
A4_HUMAN	APP	physical	21832049
SF3B4_HUMAN	SF3B4	physical	22939629
SF3B3_HUMAN	SF3B3	physical	22939629
SMD1_HUMAN	SNRPD1	physical	22939629
SF3B5_HUMAN	SF3B5	physical	22939629
SMD3_HUMAN	SNRPD3	physical	22939629
SRSF9_HUMAN	SRSF9	physical	22939629
YBOX1_HUMAN	YBX1	physical	22939629
TCEA1_HUMAN	TCEA1	physical	22939629
THOC1_HUMAN	THOC1	physical	22939629
TR150_HUMAN	THRAP3	physical	22939629
TMED9_HUMAN	TMED9	physical	22939629
TMOD2_HUMAN	TMOD2	physical	22939629
TPM1_HUMAN	TPM1	physical	22939629
SIM20_HUMAN	SMIM20	physical	22939629
TPM2_HUMAN	TPM2	physical	22939629
VASP_HUMAN	VASP	physical	22939629
TIF1A_HUMAN	TRIM24	physical	22939629
TOX4_HUMAN	TOX4	physical	22939629
PR40A_HUMAN	PRPF40A	physical	22365833
SF3B4_HUMAN	SF3B4	physical	22365833
U2AF1_HUMAN	U2AF1	physical	22365833
HNRPC_HUMAN	HNRNPC	physical	22365833
PRP8_HUMAN	PRPF8	physical	22365833
U520_HUMAN	SNRNP200	physical	22365833
LSM2_HUMAN	LSM2	physical	22365833
LSM3_HUMAN	LSM3	physical	22365833
PRPF3_HUMAN	PRPF3	physical	22365833
SYF1_HUMAN	XAB2	physical	22365833
DHX16_HUMAN	DHX16	physical	22365833
SLU7_HUMAN	SLU7	physical	22365833
RBM8A_HUMAN	RBM8A	physical	22365833
THOC1_HUMAN	THOC1	physical	22365833
F10C1_HUMAN	FRA10AC1	physical	22365833
ZN830_HUMAN	ZNF830	physical	22365833
RBM7_HUMAN	RBM7	physical	22365833
PCBP2_HUMAN	PCBP2	physical	22365833
TOE1_HUMAN	TOE1	physical	22365833
TTC14_HUMAN	TTC14	physical	22365833
ZCH10_HUMAN	ZCCHC10	physical	22365833
R113A_HUMAN	RNF113A	physical	22365833
KDM1A_HUMAN	KDM1A	physical	23455924
COPB_HUMAN	COPB1	physical	26344197
COPE_HUMAN	COPE	physical	26344197
COPG1_HUMAN	COPG1	physical	26344197
PSME3_HUMAN	PSME3	physical	26344197
SF3B3_HUMAN	SF3B3	physical	26344197
SF3B5_HUMAN	SF3B5	physical	26344197
SF3B6_HUMAN	SF3B6	physical	26344197

Drug and Disease Associations

Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.

Regulatory Network of SF3B2_HUMAN

Related Literatures of Post-Translational Modification

Acetylation
Reference	PubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-275, AND MASS SPECTROMETRY.	19608861 [Abstract]
Phosphorylation
Reference	PubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; SER-309; SER-360;SER-362 AND THR-780, AND MASS SPECTROMETRY.	19690332 [Abstract]
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; SER-309 ANDTHR-780, AND MASS SPECTROMETRY.	19413330 [Abstract]
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-435 ANDSER-436, AND MASS SPECTROMETRY.	18318008 [Abstract]
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-201; THR-217; SER-289;SER-307; SER-309; THR-311; SER-431; SER-435; SER-436 AND THR-780, ANDMASS SPECTROMETRY.	18669648 [Abstract]
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307 AND SER-309, ANDMASS SPECTROMETRY.	18691976 [Abstract]
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309 AND THR-311, ANDMASS SPECTROMETRY.	18187866 [Abstract]
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289, AND MASSSPECTROMETRY.	17525332 [Abstract]
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343; SER-360; SER-431;SER-435; SER-436; SER-778 AND THR-780, AND MASS SPECTROMETRY.	17287340 [Abstract]
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307 AND SER-309, ANDMASS SPECTROMETRY.	15302935 [Abstract]
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362; SER-416; SER-431;SER-435 AND SER-436, AND MASS SPECTROMETRY.	17081983 [Abstract]

show